Education
About Us
Working with TipRanks
Follow Us
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
Lexeo Therapeutics, Inc. (LXEO) Ownership Overview
1.60% Insiders
11.26% Mutual Funds
44.80% Other Institutional Investors
6.58% ETFs
35.76% Public Companies and
Individual Investors
The ownership structure of Lexeo Therapeutics, Inc. (LXEO) stock is a mix of institutional, retail, and individual investors. Approximately 62.64% of the company’s stock is owned by Institutional Investors, 1.60% is owned by Insiders, and 35.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 21, 2025 | xxxxxxxxxxxxx | $6553 | |
| Feb 21, 2025 | Richard Nolan Townsend Ceo,director | xxxxxxxxxxxxx | $19078 |
| Feb 21, 2025 | Eric Adler Cmo | xxxxxxxxxxxxx | $10403 |
| Feb 21, 2025 | xxxxxxxxxxxxx | $9265 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5650186 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $7794904 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $14501662 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,203,900 | Institution | 6.67% | 6,523,544 | |
| 1,234,834 | Institution | 3.73% | 3,655,109 | |
| 1,184,636 | Institution | 3.58% | 3,506,523 | |
| 1,158,617 | Institution | 3.50% | 3,429,506 | |
| 1,051,590 | Institution | 3.18% | 3,112,706 | |
| 1,042,125 | Institution | 3.15% | 3,084,690 | |
| 912,027 | Institution | 2.76% | 2,699,600 | |
| 858,691 | Institution | 2.60% | 2,541,725 | |
| 682,037 | Institution | 2.06% | 2,018,830 | |
| 546,554 | Institution | 1.65% | 1,617,800 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,234,834 | Institution | 3.73% | 3,655,109 | |
| 912,027 | Institution | 2.76% | 2,699,600 | |
| 682,037 | Institution | 2.06% | 2,018,830 | |
| 256,368 | Institution | 0.78% | 758,849 | |
| 255,459 | Institution | 0.77% | 756,159 | |
| 135,938 | Institution | 0.41% | 402,376 | |
| 65,000 | Institution | 0.20% | 192,400 | |
| 63,874 | Institution | 0.19% | 189,067 | |
| 31,235 | Institution | 0.09% | 92,456 | |
| 16,185 | Institution | 0.05% | 47,908 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 616,325 | Institution | 1.86% | 1,916,771 | |
| 507,158 | Institution | 1.53% | 1,450,472 | |
| 404,869 | Institution | 1.22% | 1,157,925 | |
| 192,298 | Institution | 0.58% | 598,047 | |
| 144,153 | Institution | 0.44% | 448,316 | |
| 107,417 | Institution | 0.32% | 307,213 | |
| 52,651 | Institution | 0.16% | 163,745 | |
| 20,278 | Institution | 0.06% | 57,995 | |
| 16,335 | Institution | 0.05% | 50,148 | |
| 13,829 | Institution | 0.04% | 42,455 |
FAQ
Who Owns Lexeo Therapeutics, Inc. (LXEO)?
According to the latest TipRanks data, approximately 44.80% of the company's stock is held by institutional investors, 1.60% is held by insiders, and 35.76% is held by retail investors.
What percentage of Lexeo Therapeutics, Inc. (LXEO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.80% of Lexeo Therapeutics, Inc. (LXEO) stock is held by institutional investors.
What percentage of Lexeo Therapeutics, Inc. (LXEO) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.76% of Lexeo Therapeutics, Inc. (LXEO) stock is held by retail investors.
Who owns the most shares of Lexeo Therapeutics, Inc. (LXEO)?
Daniel Sundheim owns the most shares of Lexeo Therapeutics, Inc. (LXEO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.